Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Accumulated Expenses: 2011-2023

Historic Accumulated Expenses for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2023 value amounting to $7.7 million.

  • SELLAS Life Sciences Group's Accumulated Expenses fell 20.77% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 20.77%. This contributed to the annual value of $7.7 million for FY2023, which is 21.70% up from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Accumulated Expenses stood at $7.7 million for FY2023, which was up 21.70% from $6.3 million recorded in FY2022.
  • In the past 5 years, SELLAS Life Sciences Group's Accumulated Expenses ranged from a high of $7.7 million in FY2023 and a low of $1.2 million during FY2019.
  • In the last 3 years, SELLAS Life Sciences Group's Accumulated Expenses had a median value of $6.3 million in 2022 and averaged $5.5 million.
  • Data for SELLAS Life Sciences Group's Accumulated Expenses shows a peak YoY soared of 138.11% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows SELLAS Life Sciences Group's Accumulated Expenses stood at $1.2 million in 2019, then soared by 63.36% to $1.9 million in 2020, then spiked by 38.00% to $2.6 million in 2021, then surged by 138.11% to $6.3 million in 2022, then increased by 21.70% to $7.7 million in 2023.